T B Niewold

Summary

Affiliation: Hospital for Special Surgery
Country: USA

Publications

  1. ncbi Anti-CCP antibody testing as a diagnostic and prognostic tool in rheumatoid arthritis
    T B Niewold
    Department of Rheumatology, Hospital for Special Surgery, 535 East 70th St, New York, NY 10021, USA
    QJM 100:193-201. 2007
  2. ncbi Systemic lupus erythematosus arising during interferon-alpha therapy for cryoglobulinemic vasculitis associated with hepatitis C
    Timothy B Niewold
    Department of Rheumatology, Hospital for Special Surgery, 535 East 70th Street, New York, NY 10021, USA
    Clin Rheumatol 24:178-81. 2005
  3. ncbi Disseminated intravascular coagulation due to cytomegalovirus infection in an immunocompetent adult treated with plasma exchange
    Timothy B Niewold
    Department of Rheumatology, Hospital for Special Surgery, New York, New York 10021, USA
    Am J Hematol 81:454-7. 2006
  4. ncbi High serum IFN-alpha activity is a heritable risk factor for systemic lupus erythematosus
    T B Niewold
    Mary Kirkland Center for Lupus Research, Hospital for Special Surgery, New York, NY, USA
    Genes Immun 8:492-502. 2007
  5. ncbi Rituximab treatment of thrombotic thrombocytopenic purpura in the setting of connective tissue disease
    Timothy B Niewold
    Department of Rheumatology Hospital for Special Surgery, New York, New York 10021, USA
    J Rheumatol 33:1194-6. 2006
  6. ncbi Concomitant interferon-alpha therapy and tumor necrosis factor alpha inhibition for rheumatoid arthritis and hepatitis C
    Timothy B Niewold
    Hospital for Special Surgery, New York, NY, USA
    Arthritis Rheum 54:2335-7. 2006
  7. ncbi Augmented interferon-alpha pathway activation in patients with Sjögren's syndrome treated with etanercept
    Clio P Mavragani
    Mary Kirkland Center for Lupus Research, Hospital for Special Surgery, 535 East 70th Street, New York, NY 10021, USA
    Arthritis Rheum 56:3995-4004. 2007
  8. ncbi Age- and sex-related patterns of serum interferon-alpha activity in lupus families
    Timothy B Niewold
    Section of Rheumatology, University of Chicago, Chicago, Illinois 60637, USA
    Arthritis Rheum 58:2113-9. 2008
  9. ncbi Association of the IRF5 risk haplotype with high serum interferon-alpha activity in systemic lupus erythematosus patients
    Timothy B Niewold
    University of Chicago, Section of Rheumatology, Chicago, IL 60637, USA
    Arthritis Rheum 58:2481-7. 2008
  10. ncbi Serum type I interferon activity is dependent on maternal diagnosis in anti-SSA/Ro-positive mothers of children with neonatal lupus
    Timothy B Niewold
    University of Chicago, Section of Rheumatology, Chicago, Illinois 60637, USA
    Arthritis Rheum 58:541-6. 2008

Detail Information

Publications13

  1. ncbi Anti-CCP antibody testing as a diagnostic and prognostic tool in rheumatoid arthritis
    T B Niewold
    Department of Rheumatology, Hospital for Special Surgery, 535 East 70th St, New York, NY 10021, USA
    QJM 100:193-201. 2007
    ..We discuss anti-CCP antibody testing in rheumatoid arthritis, with an emphasis on diagnostic performance, prognostic capability, and relevance to pathogenesis and new treatment paradigms in rheumatoid arthritis...
  2. ncbi Systemic lupus erythematosus arising during interferon-alpha therapy for cryoglobulinemic vasculitis associated with hepatitis C
    Timothy B Niewold
    Department of Rheumatology, Hospital for Special Surgery, 535 East 70th Street, New York, NY 10021, USA
    Clin Rheumatol 24:178-81. 2005
    ..The development of SLE during therapy with IFN-alpha could be due to direct immunomodulation by IFN-alpha, and review of experimental data and prior case reports suggests a pathogenic role for IFN-alpha in SLE...
  3. ncbi Disseminated intravascular coagulation due to cytomegalovirus infection in an immunocompetent adult treated with plasma exchange
    Timothy B Niewold
    Department of Rheumatology, Hospital for Special Surgery, New York, New York 10021, USA
    Am J Hematol 81:454-7. 2006
    ..The one previously reported immunocompetent patient with DIC due to acute CMV infection died from the illness despite traditional supportive measures. Plasma exchange is a novel therapy that should be considered in this situation...
  4. ncbi High serum IFN-alpha activity is a heritable risk factor for systemic lupus erythematosus
    T B Niewold
    Mary Kirkland Center for Lupus Research, Hospital for Special Surgery, New York, NY, USA
    Genes Immun 8:492-502. 2007
    ..The frequency of high IFN-alpha activity was similar across all studied ethnic backgrounds. These data suggest that high serum IFN-alpha activity is a complex heritable trait, which plays a primary role in SLE pathogenesis...
  5. ncbi Rituximab treatment of thrombotic thrombocytopenic purpura in the setting of connective tissue disease
    Timothy B Niewold
    Department of Rheumatology Hospital for Special Surgery, New York, New York 10021, USA
    J Rheumatol 33:1194-6. 2006
    ..Rituximab should be considered in this complex clinical setting, because it may decrease the production of multiple pathogenic autoantibodies...
  6. ncbi Concomitant interferon-alpha therapy and tumor necrosis factor alpha inhibition for rheumatoid arthritis and hepatitis C
    Timothy B Niewold
    Hospital for Special Surgery, New York, NY, USA
    Arthritis Rheum 54:2335-7. 2006
  7. ncbi Augmented interferon-alpha pathway activation in patients with Sjögren's syndrome treated with etanercept
    Clio P Mavragani
    Mary Kirkland Center for Lupus Research, Hospital for Special Surgery, 535 East 70th Street, New York, NY 10021, USA
    Arthritis Rheum 56:3995-4004. 2007
    ..To address the hypothesis that tumor necrosis factor blockade can result in increased levels of interferon-alpha (IFNalpha) and BAFF, we quantified those mediators in plasma from etanercept- and placebo-treated SS patients...
  8. ncbi Age- and sex-related patterns of serum interferon-alpha activity in lupus families
    Timothy B Niewold
    Section of Rheumatology, University of Chicago, Chicago, Illinois 60637, USA
    Arthritis Rheum 58:2113-9. 2008
    ..The purpose of this study was to determine whether serum IFNalpha activity in SLE patients and their healthy first-degree relatives is highest in early adulthood, when the incidence of SLE is greatest...
  9. ncbi Association of the IRF5 risk haplotype with high serum interferon-alpha activity in systemic lupus erythematosus patients
    Timothy B Niewold
    University of Chicago, Section of Rheumatology, Chicago, IL 60637, USA
    Arthritis Rheum 58:2481-7. 2008
    ..The aim of this study was to determine whether the IRF5 SLE risk haplotype mediates the risk of SLE by predisposing patients to the development of high levels of serum IFNalpha activity...
  10. ncbi Serum type I interferon activity is dependent on maternal diagnosis in anti-SSA/Ro-positive mothers of children with neonatal lupus
    Timothy B Niewold
    University of Chicago, Section of Rheumatology, Chicago, Illinois 60637, USA
    Arthritis Rheum 58:541-6. 2008
    ....
  11. ncbi Interferon alpha-induced lupus: proof of principle
    Timothy B Niewold
    J Clin Rheumatol 14:131-2. 2008
  12. ncbi 59-year-old woman with progressive dyspnea on exertion
    Timothy B Niewold
    Mayo Graduate School of Medicine, Mayo Clinic College of Medicine, Rochester, Minn 55905, USA
    Mayo Clin Proc 79:1567-70. 2004
  13. ncbi 78-year-old woman with fever, weight loss, and rash
    Timothy B Niewold
    Mayo Graduate School of Medicine, Mayo Clinic, Rochester, Minn 55905, USA
    Mayo Clin Proc 78:635-8. 2003